您的位置: 首页 > 农业专利 > 详情页

recombinant or isolated polypeptide, nucleic acid molecule, diagnostic kit for detecting hepatitis virus infection, vaccine composition, pharmaceutical composition, recombinant expression vector, transformed host cell and use of recombinant or isolated polypeptide
专利权人:
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO.; LTD.
发明人:
JUN ZHANG,NINGSHAO XIA,SHAOWEI LI,SHENGXIANG GE,YING GU,ZHIQIANG HE
申请号:
BR122015016384
公开号:
BR122015016384B1
申请日:
2002.11.08
申请国别(地区):
BR
年份:
2017
代理人:
摘要:
Summary "recombinant or isolated polypeptide, nucleic acid molecule, diagnostic kit for detecting hepatitis e infection, vaccine composition, pharmaceutical composition, recombinant expression vector, transformed host cell and use of recombinant or isolated polypeptide" herein The invention relates to the monoclonal antibody specifically linked to the polypeptide (s) comprising the amino acid sequence as represented in sequence: hepatitis virus orf2 and or conserved variants or active fragments thereof, or other monoclonal antibodies against orf2 which may cross-react with said monoclonal antibody of the present invention, and its degraded nucleotide sequence or sequence; for the antigenic determinant in hepatitis virus orf2 and; for a method for classifying isolated or recombined polypeptide or peptide analogue, which has the same property of specifically binding to said 8c11 and / or 8h3 monoclonal antibody as said hepatitis virus orf2 antigenic determinant 1) or 3) and; for polypeptide or peptide analog classified by the above method and its nucleotide sequence or degenerate sequence thereof; for use of said polypeptide or polypeptide analog in the preparation of a medicament for the diagnosis and / or prevention of hepatitis virus infection and; for a hepatitis virus infection diagnostic kit and and a vaccine composition for hepatitis virus infection prophylaxis e; for using said monoclonal antibodies or conserved active fragments or variants thereof in the preparation of a medicament for the diagnosis, prophylaxis and / or treatment of hepatitis virus infection and; for pharmaceutical composition for prophylaxis and / or treatment of hepatitis virus infection and and a method for prophylaxis and / or treatment of hepatitis virus infection e; for a recombinant expression vector comprising said nucleotide molecule in the present invention and a host cell transformed with said recombinant expression vector which is capable of expressing the monoclonal antibody and
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充